Related references
Note: Only part of the references are listed.CheckMate 171: A phase 2 trial of nivolumab in patients with previously treated advanced squamous non-small cell lung cancer, including ECOG PS 2 and elderly populations
Enriqueta Felip et al.
EUROPEAN JOURNAL OF CANCER (2020)
A Randomized Open-Label Phase III Trial Evaluating the Addition of Denosumab to Standard First-Line Treatment in Advanced NSCLC: The European Thoracic Oncology Platform (ETOP) and European Organisation for Research and Treatment of Cancer (EORTC) SPLENDOUR Trial
Solange Peters et al.
JOURNAL OF THORACIC ONCOLOGY (2020)
Current Status of Adverse Events Related with Opioid Analgesics in Japan: Assessment Based on Japanese Adverse Drug Event Report Database
Yukio Suga et al.
BIOLOGICAL & PHARMACEUTICAL BULLETIN (2019)
The evolution and understanding of skeletal complication endpoints in clinical trials of tumors with metastasis to the bone
A. Hussain et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2019)
The Japanese Lung Cancer Society Guideline for non-small cell lung cancer, stage IV
Hiroaki Akamatsu et al.
INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY (2019)
Clinical associations and prognostic value of site-specific metastases in non-small cell lung cancer: A population-based study
Zihan Xu et al.
ONCOLOGY LETTERS (2019)
Sex and survival in non-small cell lung cancer: A nationwide cohort study
Cecilia Radkiewicz et al.
PLOS ONE (2019)
Metastatic bone disease: Pathogenesis and therapeutic options Up-date on bone metastasis management
Stella D'Oronzo et al.
JOURNAL OF BONE ONCOLOGY (2019)
Ten-year experience of the multidisciplinary Osteoncology Center
Alberto Bongiovanni et al.
SUPPORTIVE CARE IN CANCER (2019)
Prospective analysis of the association between skeletal-related events and quality of life in patients with advanced lung cancer (CSP-HOR13)
Hiroshi Kunikane et al.
ONCOLOGY LETTERS (2019)
Multicenter study of zoledronic acid administration in non-small-cell lung cancer patients with bone metastasis: Thoracic Oncology Research Group (TORG) 1017
Yoshiro Nakahara et al.
MOLECULAR AND CLINICAL ONCOLOGY (2019)
1384PDPembrolizumab in performance status 2 patients with non-small cell lung cancer (NSCLC): Results of the PePS2 trial
G Middleton et al.
ANNALS OF ONCOLOGY (2018)
Impact of denosumab use on the survival of untreated non-squamous non-small cell lung cancer patients with bone metastases
Hibiki Udagawa et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2017)
Alectinib for Patients with ALK Rearrangement-Positive Non-Small Cell Lung Cancer and a Poor Performance Status (Lung Oncology Group in Kyushu 1401)
Eiji Iwama et al.
JOURNAL OF THORACIC ONCOLOGY (2017)
Skeletal-related events and overall survival of patients with bone metastasis from nonsmall cell lung cancer - A retrospective analysis
Pengyu Kong et al.
MEDICINE (2017)
Prevalence of osteoporosis and related lifestyle and metabolic factors of postmenopausal women and elderly men: A cross-sectional study in Gansu province, Northwestern of China
Limin Tian et al.
MEDICINE (2017)
Palliative radiation therapy for bone metastases: Update of an ASTRO Evidence-Based Guideline
Stephen Lutz et al.
PRACTICAL RADIATION ONCOLOGY (2017)
The incidence and clinical impact of bone metastases in non-small cell lung cancer
Michael Kuchuk et al.
LUNG CANCER (2015)
Natural History of Non-Small-Cell Lung Cancer with Bone Metastases
Santini Daniele et al.
SCIENTIFIC REPORTS (2015)
Specific organ metastases and survival in metastatic non-small-cell lung cancer
Tomohiro Tamura et al.
MOLECULAR AND CLINICAL ONCOLOGY (2015)
Investigation of the freely available easy-to-use software 'EZR' for medical statistics
Y. Kanda
BONE MARROW TRANSPLANTATION (2013)
A meta-analysis of 18FDG-PET-CT, 18FDG-PET, MRI and bone scintigraphy for diagnosis of bone metastases in patients with lung cancer
Xinhua Qu et al.
EUROPEAN JOURNAL OF RADIOLOGY (2012)
Randomized, Double-Blind Study of Denosumab Versus Zoledronic Acid in the Treatment of Bone Metastases in Patients With Advanced Cancer (Excluding Breast and Prostate Cancer) or Multiple Myeloma
David H. Henry et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Predictors of skeletal-related events in non-small cell lung cancer patients with bone metastases
Jong-Mu Sun et al.
LUNG CANCER (2011)
Prevalence of knee osteoarthritis, lumbar spondylosis, and osteoporosis in Japanese men and women: the research on osteoarthritis/osteoporosis against disability study
Noriko Yoshimura et al.
JOURNAL OF BONE AND MINERAL METABOLISM (2009)
First-Line Gefitinib for Patients With Advanced Non-Small-Cell Lung Cancer Harboring Epidermal Growth Factor Receptor Mutations Without Indication for Chemotherapy
Akira Inoue et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Risk factors for skeletal-related events in patients with non-small cell lung cancer treated by chemotherapy
Ikuo Sekine et al.
LUNG CANCER (2009)
Palliative radiotherapy trials for bone metastases: A systematic review
Edward Chow et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
The significance of skeletal-related events for the health-related quality of life of patients with metastatic prostate cancer
KP Weinfurt et al.
ANNALS OF ONCOLOGY (2005)